Update on the Phase 4 Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 228.48 +0.88 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.60 | 52 Week High | $333.65 | |||
| Open | $225.87 | 52 Week Low | $223.02 | |||
| Day High | $228.58 | P/E | 29.25 | |||
| Day Low | $225.51 | EPS | $7.81 | |||
| Volume | 50,178 | |||||

